A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma (GALACCTIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00924989
Recruitment Status : Completed
First Posted : June 19, 2009
Last Update Posted : September 5, 2018
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 11, 2012
  Actual Study Completion Date : October 8, 2012
  Certification/Extension First Submitted : July 10, 2013